Alfimeprase for Thrombolysis in Acute Peripheral Arterial Occlusion

Completed · Phase 2

Conditions studied: Arterial Occlusive Diseases, Peripheral Vascular Diseases, Thrombosis

In brief

This trial is for patients with acute occlusion of one of the arteries supplying blood to the leg. The trial is designed to determine the safety and activity of a novel clot dissolving (thrombolytic) drug (alfimeprase).

Key facts

Study ID

NCT00073554

Run by

ARCA Biopharma, Inc.

People needed

100

Starts

2003-06-01

Last updated by the study team

2009-12-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Cleveland Clinic Foundation — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.